Across 32,598 women in the development programmes, 164 unplanned pregnancies were recorded
Patients should be cautious of services that prescribe semaglutide without adequate medical assessment or follow-up, as this may compromise safety and treatment effectiveness
Additionally, individuals must have a stable medical history and current health status and have previously attempted weight loss with little success
FDA Drug Safety Communication: FDA investigating reports of possible increased risk of pancreatitis and pre-cancerous findings of the pancreas from incretin mimetic drugs for type 2 diabetes
However, now the expert journal "Science" has declared the group of drugs, which also includes injections for weight loss, "a scientific breakthrough in 2023." These drugs, the explanation states, not only change the way in which obesity is treated, but also how it should be understood - "as a chronic disease with biological causes", and not as "a mere stumbling of the will"
Ozempic was originally developed to lower blood sugar in patients with type 2 diabetes
